Innerdyne licenses siloxane coating to US Surgical:
This article was originally published in Clinica
US Surgical and InnerDyne have reached agreement to license InnerDyne's proprietary siloxane covering for minimally-invasive surgical products. US Surgical will test coated samples and, if successful, Sunnyvale, California-based InnerDyne will transfer the process to a US Surgical factory. InnerDyne will get a licence fee and royalty payments, though the amounts were undisclosed.
You may also be interested in...
India’s Sun Pharma has been denied leave to appeal against a US court decision rejecting the company’s bid for dismissal of a multi-district antitrust lawsuit.
Former Sandoz executive Hector Armando Kellum has admitted involvement in a US generic price-fixing conspiracy, the US Department of Justice has announced.
The last year of the run up to the full implementation of the MDR has been characterized by a flurry of new documents and measures, but industry is adamant that medtech is heading for a crisis that will impact industry and patients alike.